WilmerHale has advised Ocular Therapeutix and Cooley has advised the underwriters.Ocular Therapeutix, Inc., an integrated biopharmaceutical company, conducted an underwritten offering of 37,909,018 shares of its…
Ocular Therapeutix Undertakes $475 Million Stock Offering

























